Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cemtrex (CETXP) EBT (2016 - 2025)

Cemtrex's EBT history spans 16 years, with the latest figure at -$20.3 million for Q4 2025.

  • For Q4 2025, EBT rose 28.81% year-over-year to -$20.3 million; the TTM value through Dec 2025 reached -$20.1 million, up 42.13%, while the annual FY2025 figure was -$28.4 million, 279.23% down from the prior year.
  • EBT reached -$20.3 million in Q4 2025 per CETXP's latest filing, down from -$3.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.7 million in Q1 2025 to a low of -$28.5 million in Q4 2024.
  • Average EBT over 5 years is -$3.5 million, with a median of -$1.3 million recorded in 2022.
  • Peak YoY movement for EBT: crashed 2195.41% in 2024, then soared 689.19% in 2025.
  • A 5-year view of EBT shows it stood at -$3.8 million in 2021, then rose by 17.88% to -$3.1 million in 2022, then surged by 59.84% to -$1.2 million in 2023, then plummeted by 2195.41% to -$28.5 million in 2024, then grew by 28.81% to -$20.3 million in 2025.
  • Per Business Quant, the three most recent readings for CETXP's EBT are -$20.3 million (Q4 2025), -$3.9 million (Q3 2025), and -$4.6 million (Q2 2025).